1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. California >
  6. Zoetis Acquires Abaxis

M&A Deal Summary

Zoetis Acquires Abaxis

On May 16, 2018, Zoetis acquired medical products company Abaxis for 2.0B USD

Acquisition Highlights
  • This is Zoetis’ 3rd transaction in the Medical Products sector.
  • This is Zoetis’ largest (disclosed) transaction.
  • This is Zoetis’ 3rd transaction in the United States.
  • This is Zoetis’ 1st transaction in California.

M&A Deal Summary
Date 2018-05-16
Target Abaxis
Sector Medical Products
Buyer(s) Zoetis
Deal Type Add-on Acquisition
Deal Value 2.0B USD
Advisor(s) Piper Sandler & Co. (Financial)
Cooley (Legal)

Target

Abaxis

Union City, California, United States
Abaxis is a developer, manufacturer, marketer and seller of portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements. Abaxis was founded in 1989 and is based in Union City, California.

Search 206,877 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Zoetis

Parsippany, New Jersey, United States
Category Company
Founded 1952
Sector Life Science
Employees13,800
Revenue 9.3B USD (2024)
DESCRIPTION

Zoetis engages in the discovery, development, manufacture and commercialization of a diverse portfolio of animal health medicines and vaccines designed to meet the real-world needs of veterinarians and the livestock farmers and companion animal owners they support. Zoetis was founded in 1952 and is based in Parsippany, New Jersey.

DEAL STATS #
Overall 7 of 13
Sector: Medical Products M&A 3 of 3
Type: Add-on Acquisition M&A Deals 7 of 12
State: California M&A 1 of 4
Country: United States M&A 3 of 8
Year: 2018 M&A 1 of 1
Size (of disclosed) 1 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-04-13 Nexvet Biopharma

Tullamore, Ireland

Nexvet Biopharma PLC is a veterinary biologic therapeutics company focused on transforming the therapeutic market for companion animals, such as dogs and cats, by developing and commercializing novel, species-specific biologics. Nexvet Biopharma is based in Tullamore, Ireland.

Buy $85M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-07-22 Platinum Performance

Buellton, California, United States

Platinum Performance is a nutrition-focused animal health company. Platinum Performance develops, manufactures and markets a broad range of premium nutritional product formulas for horses as well as a smaller range of petcare brands and human supplements. Platinum Performance was founded in 1996 and is based in Buellton, California.

Buy -
Mergr

Product

Company

Legal